Meta-analysis: Eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 10, 2013, Pages 1195-1205

  Xie, Tingting ^a   Cui, Xiaobing ^a   Zheng, Haoxuan ^a   Chen, Dong ^a   He, Ling ^a   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; INCIDENCE; MEDLINE; META ANALYSIS; PATHOGEN CLEARANCE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE; PROTON PUMP INHIBITORS; PUBLICATION BIAS; RESEARCH DESIGN; RISK ASSESSMENT; SYMBIOSIS;

EID: 84883656775     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328363e2c7     Document Type: Article

References (85)

1. Dent J, El-Serag HB, Wallander M.A., Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54:710-717. (Pubitemid 40559260)
2. Kang JY. Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20:705-717. (Pubitemid 39319226)
3. Fujiwara Y, Higuchi K, Watanabe Y., Shiba M, Watanabe T, Tominaga K., et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol 2005; 20:26-29. (Pubitemid 40143629)
4. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326:737.
5. Fock KM, Ang TL Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 2010; 25:479-486.
6. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-69.
7. Stadtlander CT, Waterbor JW Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20:2195-2208.
8. Nomura AM, Kolonel LN, Miki K, Stemmermann G.N., Wilkens LR, Goodman MT, et al Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis 2005; 191:2075-2081. (Pubitemid 40800578)
9. Calleja JL, Suarez M, De Tejada AH, Navarro A. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Dig Dis Sci 2005; 50:432-439. (Pubitemid 40543727)
10. Malfertheiner P, Dent J, Zeijlon L., Stemmermann GN, Wilkens LR, Goodman MT, et al Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized trial programme. Aliment Pharmacol Ther 2002; 16:1431-1442. (Pubitemid 34953583)
11. Vakil N, Talley NJ, Stolte M, Sundin M., Junghard O, Bolling-Sternevald O. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2006; 24:55-63. (Pubitemid 43894005)
12. Xia HH, Phung N, Altiparmak E., Berry A, Matheson M, Talley NJ Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in western Sydney between 1990 and 1998. Dig Dis Sci 2001; 46:2716-2723. (Pubitemid 33141044)
13. Ashktorab H, Entezari O, Nouraie M., Dowlati E, Frederick W, Woods A., et al. Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci 2012; 57:2924-2928.
14. Hamada H, Haruma K, Mihara M., Kamada T, Yoshihara M, Sumii K., et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14:729-735. (Pubitemid 30352739)
15. Take S, Mizuno M, Ishiki K., Nagahara Y, Yoshida To, Yokota K, et al Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: prospective endoscopic evaluation. J Gastroenterol Hepatol 2009; 24:107-113.
16. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon ATR, Bazzoli F, et al. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut 2012; 61:646-664.
17. Armstrong D, Bennett JR, Blum A.L., Dent J., De Dombal FT, Galmiche JP, et al The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111:85-92. (Pubitemid 26226887)
18. Jadad AR, Moore RA, Carroll D, Jenkinson C., Reynolds DJ, Gavaghan DJ, McQuay HJ Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12. (Pubitemid 26120810)
19. Higgins JPT, Thompson SG, Deeks J.J., Altman DG Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560. (Pubitemid 37088507)
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634. (Pubitemid 27387172)
21. Abdollahi A, Morteza A, Khalilzadeh O., Zandieh A, Asgarshirazi M. The role of Helicobacter pylori infection in gastro-oesophageal reflux in Iranian children. Ann Trop Paediatr 2011; 31:53-57.
22. Chung SJ, Lim SH, Choi J, Kim D., Kim YS, Park MJ, et al Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched case-control study of 5,616 health check-up Koreans. J Neurogastroenterol Motil 2011; 17:267-273.
23. El-Serag H.B., Sonnenberg A, Jamal M.M., Inadomi JM, Crooks LA, Feddersen RM Corpus gastritis is protective against reflux oesophagitis. Gut 1999; 45:181-185. (Pubitemid 29333765)
24. Hackelsberger A, Schultze V, Gunther T., von Arnim U, Manes G, Malfertheiner P. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 1998; 10:465-468. (Pubitemid 28306537)
25. Haruma K, Hamada H, Mihara M., Kamada T, Yoshihara M, Sumii K., et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2000; 5:24-29.
26. Mahdi BM. The relationship between Helicobacter pylori infection and gastro-esophageal reflux disease. N Am J Med Sci 2011; 3:142-145.
27. Goldblum JR, Vicari JJ, Falk G.W., Rice TW, Peek RM, Easley K, Richter JE Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998; 114:633-639. (Pubitemid 28160397)
28. Koike T, Ohara S, Sekine H., Iijima K, Kato K, Shimosegawa T., Toyota T. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999; 94:3468-3472.
29. Lai CH, Poon SK, Chen Y.C., Chang CS, Wang WC Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease. Helicobacter 2005; 10:577-585.
30. Liston R, Pitt MA, Banerjee AK Reflux oesophagitis and Helicobacter pylori infection in elderly patients. Postgrad Med J 1996; 72:221-223. (Pubitemid 26114283)
31. Loffeld RJ, van der Putten AB. Helicobacter pylori and gastro-oesophageal reflux disease: a cross-sectional epidemiological study. Neth J Med 2004; 62:188-191. (Pubitemid 39117769)
32. Masjedizadeh R, Hajiani E, Moezardalan K., Samie S, Ehsani-Ardakani MJ, Daneshmand A, Zali MRH. Pylori infection and reflux oesophagitis: a case-control study. World J Gastroenterol 2006; 12:5658-5662. (Pubitemid 44594040)
33. Newton M, Bryan R, Burnham W.R., Kamm MA Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997; 40:9-13. (Pubitemid 27079743)
34. Varanasi RV, Fantry GT, Wilson KT Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998; 3:188-194. (Pubitemid 128656486)
35. Garrido Serrano A., Lepe Jimenez JA, Guerrero Igea FJ, Perianes Hernandez C. Helicobacter pylori and gastroesophageal reflux disease. Rev Esp Enferm Dig 2003; 95:788-790, 785-787.
36. Werdmuller BF, Loffeld RJ Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42:103-105. (Pubitemid 27059929)
37. Yerra LN, Bhasin DK, Panigrahi D, Vaiphei K., Sharma BC, Ray P. Prevalence of Helicobacter pylori infection in patients with reflux oesophagitis. Trop Gastroenterol 1999; 20:175-177.
38. Vaira D, Vakil N, Rugge M., Gatta L, Ricci C, Menegatti M., et al. Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects. Gut 2003; 52:1543-1547. (Pubitemid 37363435)
39. Labenz J, Blum AL, Bayerdorffer E, Meining A., Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112:1442-1447. (Pubitemid 27181366)
40. Kawanishi M. Development of reflux esophagitis following Helicobacter pylori eradication. J Gastroenterol 2005; 40:1024-1028. (Pubitemid 43055285)
41. Fallone CA, Barkun AN, Friedman G, Mayrand S., Loo V, Beech R, et al Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95:914-920. (Pubitemid 30196725)
42. Inoue H, Imoto I, Taguchi Y., Kuroda M, Nakamura M, Horiki N., et al. Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia. Scand J Gastroenterol 2004; 39:1061-1065. (Pubitemid 39536393)
43. Kim N, Lee SW, Kim J.I., Baik GH, Kim SJ, Seo GS, et al Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study. Gut Liver 2011; 5:437-446.
44. Levine A, Milo T, Broide E., Wine E, Dalal I, Boaz M., et al. Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics 2004; 113:54-58. (Pubitemid 38057493)
45. McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. Am J Gastroenterol 2000; 95:101-105. (Pubitemid 30041542)
46. Murai T, Miwa H, Ohkura R., Iwazaki R, Nagahara A, Sato K., et al. The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population. Aliment Pharmacol Ther 2000; 14 (Suppl 1): 161-165. (Pubitemid 30199120)
47. Tsukada K, Katoh H, Miyazaki T., Fukuchi M, Kuwano H, Kimura H., et al. Factors associated with the development of reflux esophagitis after Helicobacter pylori eradication. Dig Dis Sci 2006; 51:539-542.
48. Befrits R, Sjostedt S, Odman B., Sorngard H, Lindberg G. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 2000; 5:202-205. (Pubitemid 34948001)
49. Bytzer P, Aalykke C, Rune S., Weywadt L, Gjorup T, Eriksen J., et al. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol 2000; 35:1023-1032.
50. Ott EA, Mazzoleni LE, Edelweiss M.I., Sander GB, Wortmann AC, Theil AL, et al Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Aliment Pharmacol Ther 2005; 21:1231-1239. (Pubitemid 40733489)
51. Harvey RF, Lane JA, Murray L.J., Harvey IM, Donovan JL, Nair P. Bristol Helicobacter Project. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ 2004; 328:1417.
52. Jonaitis L, Kupcinskas J, Kiudelis G., Kupcinskas L. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Medicina (Kaunas) 2010; 46:454-459.
53. Moayyedi P, Bardhan C, Young L., Dixon MF, Brown L, Axon AT Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001; 121:1120-1126. (Pubitemid 33022092)
54. Kim N, Lim SH, Lee KH No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea. Dig Dis Sci 2001; 46:2724-2732. (Pubitemid 33143818)
55. Nam SY, Choi IJ, Ryu K.H., Kim BC, Kim CG, Nam BH Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol 2010; 105:2153-2162.
56. Wu JC, Chan FK, Ching J.Y., Leung WK, Hui Y, Leong R, et al Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004; 53:174-179. (Pubitemid 38125502)
57. Yaghoobi M, Farrokhyar F, Yuan Y., Hunt RH Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105:1007-1013, quiz 1006, 1014.
58. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A., Gasbarrini G, Gasbarrini A, Camilleri M. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 18:279-289. (Pubitemid 37046707)
59. Saad AM, Choudhary A, Bechtold ML Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol 2012; 47:129-135.
60. Smith JG, Li W, Rosson RS Prevalence, clinical and endoscopic predictors of Helicobacter pylori infection in an urban population. Conn Med 2009; 73:133-137.
61. Fan X, Snyder N. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci 2009; 54:572-577.
62. Sharma P, Wani S, Romero Y., Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol 2008; 103:2669-2680.
63. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997; 100:759-762. (Pubitemid 27371691)
64. Mattsson A, Lonroth H, Quiding-Jarbrink M, Svennerholm AM Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J Clin Invest 1998; 102:51-56. (Pubitemid 28323829)
65. Shirota T, Kusano M, Kawamura O., Horikoshi T, Mori M, Sekiguchi T. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol 1999; 34:553-559. (Pubitemid 29500317)
66. Wren AM, Bloom SR Gut hormones and appetite control. Gastroenterology 2007; 132:2116-2130. (Pubitemid 46693747)
67. El-Serag H.B., Graham DY, Satia J.A., Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005; 100:1243-1250. (Pubitemid 40904344)
68. Thor PJ, Blaut U. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease. J Physiol Pharmacol 2006; 57 (Suppl 3): 81-90. (Pubitemid 44617512)
69. Peek RM J.r., Miller GG, Tham K.T., Perez-Perez GI, Zhao X, Atherton J.C., Blaser MJ. Heightened inflammatory response and cytokine expression in vivo to cagA + Helicobacter pylori strains. Lab Invest 1995; 73:760-770. (Pubitemid 26002335)
70. Webb PM, Crabtree JE, Forman D. Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology 1999; 116:269-276. (Pubitemid 29055348)
71. Bayerdorffer E, Lehn N, Hatz R., Mannes GA, Oertel H, Sauerbruch T, Stolte M. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992; 102:1575-1582.
72. Crabtree JE, Taylor JD, Wyatt J.I., Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338:332-335.
73. Sharma SA, Tummuru MK, Miller G.G., Blaser MJ Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 1995; 63:1681-1687.
74. Tomb JF, White O, Kerlavage A.R., Clayton RA, Sutton GG, Fleischmann RD, et al The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388:539-547. (Pubitemid 27339996)
75. Kuipers EJ, Perez-Perez GI, Meuwissen S.G., Blaser MJ Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87:1777-1780.
76. Sekine H, Iijima K, Koike T., Abe Y, Imatani A, Kato K., et al. Regional differences in the recovery of gastric acid secretion after Helicobacter pylori eradication: evaluations with Congo red chromoendoscopy. Gastrointest Endosc 2006; 64:678-685. (Pubitemid 44573113)
77. Naylor GM, Gotoda T, Dixon M., Shimoda T, Gatta L, Owen R., et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006; 55:1545-1552. (Pubitemid 44629199)
78. El-Omar E.M., Carrington M, Chow W.H., McColl KE, Bream JH, Young HA, et al Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402. (Pubitemid 30164342)
79. Weel JF, van der Hulst RW, Gerrits Y, Roorda P, Feller M, Dankert J, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996; 173:1171-1175. (Pubitemid 26251460)
80. Van Doorn L.J., Figueiredo C, Sanna R., Plaisier A, Schneeberger P, de Boer W, Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115:58-66. (Pubitemid 28307288)
81. Cover TL, Dooley CP, Blaser MJ Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58:603-610. (Pubitemid 20072620)
82. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, van der Ende A. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 1997; 35:1344-1347. (Pubitemid 27216792)
83. Shimoyama T, Fukuda S, Tanaka M., Mikami T, Munakata A, Crabtree JE CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol 1998; 51:225-228. (Pubitemid 28216080)
84. Blaser MJ, Perez-Perez GI, Kleanthous H., Cover TL, Peek RM, Chyou PH, et al Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
85. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301. (Pubitemid 27145639)